Search Results

Desmopressin dose requirements in patients with permanent arginine vasopressin deficiency: a tertiary center experience.

• Authors : Varaldo E; Division of Endocrinology, Diabetology and Metabolism, Department of Medical Sciences, University of Turin, Corso Dogliotti, 14, 10126, Turin, Italy. .; Sibilla M

Subjects: Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/administration & dosage ; Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/therapeutic use ; Arginine Vasopressin*/Arginine Vasopressin*/Arginine Vasopressin*/deficiency

• Source: Pituitary [Pituitary] 2024 Oct; Vol. 27 (5), pp. 714-722. Date of Electronic Publication: 2024 Sep 12.Publisher: Kluwer Academic Publishers Country of Publication: United States NLM ID: 9814578 Publication Model: Print-Electronic Cited Medium: Internet

Record details

GLP-1 receptor agonists may enhance the effects of desmopressin in individuals with AVP deficiency: a case series and proposed mechanism.

• Authors : Nakhleh A; Maccabi Healthcare Services, Haifa, Israel. .; Institute of Endocrinology, Diabetes and Metabolism, Rambam Health Care Campus, Haifa, Israel. .

Subjects: Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/pharmacology ; Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/therapeutic use ; Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/agonists

• Source: Pituitary [Pituitary] 2024 Oct; Vol. 27 (5), pp. 731-736. Date of Electronic Publication: 2024 Sep 06.Publisher: Kluwer Academic Publishers Country of Publication: United States NLM ID: 9814578 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Electroencephalography-based investigation of the effects of oral desmopressin on improving slow-wave sleep time in nocturnal polyuria patients (the DISTINCT study): A single-arm, open-label, single-assignment trial.

• Authors : Torimoto K; Department of Urology, Nara Medical University Hospital, Kashihara, Japan.; Gotoh D

Subjects: Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/administration & dosage ; Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/pharmacology ; Polyuria*/Polyuria*/Polyuria*/drug therapy

• Source: Neurourology and urodynamics [Neurourol Urodyn] 2024 Sep; Vol. 43 (7), pp. 1559-1565. Date of Electronic Publication: 2024 Apr 12.Publisher: Alan R. Liss Country of Publication: United States NLM ID: 8303326 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Improvement of medication adherence for desmopressin by adjusting the prescription dosage in male patients with overactive bladder: A claims database analysis.

• Authors : Tsubouchi K; Department of Urology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.; Maeda T

Subjects: Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/drug therapy ; Medication Adherence*/Medication Adherence*/Medication Adherence*/statistics & numerical data ; Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/administration & dosage

• Source: Neurourology and urodynamics [Neurourol Urodyn] 2024 Nov; Vol. 43 (8), pp. 2207-2213. Date of Electronic Publication: 2024 Jul 09.Publisher: Alan R. Liss Country of Publication: United States NLM ID: 8303326 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Desmopressin use in major cardiac surgery is associated with renal impairment: a retrospective single-center analysis.

• Authors : Koköfer A; Department of Anaesthesiology, Perioperative Medicine and Intensive Care Medicine, Paracelsus Medical University Salzburg, 5020, Salzburg, Austria. .; Rodemund N

Subjects: Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/therapeutic use ; Cardiac Surgical Procedures*/Cardiac Surgical Procedures*/Cardiac Surgical Procedures*/methods ; Cardiac Surgical Procedures*/Cardiac Surgical Procedures*/Cardiac Surgical Procedures*/adverse effects

• Source: BMC anesthesiology [BMC Anesthesiol] 2024 Oct 07; Vol. 24 (1), pp. 357. Date of Electronic Publication: 2024 Oct 07.Publisher: BioMed Central Country of Publication: England NLM ID: 100968535 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2253

Record details

Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs.

• Authors : Daniel MY; Hematology and Transfusion Department, Institut National de la Santé et de la Recherche Médicale, Centre Hospitalier Universitaire de Lille, Institut Pasteur de Lille, Université de Lille, U1011-European Genomic Institute for Diabetes, Lille, France. Electronic address: https://twitter.com/DanielMelanieMD.; Ternisien C

Subjects: Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/therapeutic use ; Phenotype* ; Hemorrhage*/Hemorrhage*/Hemorrhage*/genetics

• Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2024 Oct; Vol. 22 (10), pp. 2702-2712. Date of Electronic Publication: 2024 Jul 09.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7836

Record details

Development of a Novel Prediction Tool for Response to First-Line Treatments of Monosymptomatic Nocturnal Enuresis: A Randomized, Controlled, International, Multicenter Study (DRYCHILD).

• Authors : Jørgensen CS; Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Subjects: Nocturnal Enuresis*/Nocturnal Enuresis*/Nocturnal Enuresis*/drug therapy ; Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/therapeutic use ; Antidiuretic Agents*/Antidiuretic Agents*/Antidiuretic Agents*/therapeutic use

• Source: The Journal of urology [J Urol] 2024 Oct; Vol. 212 (4), pp. 539-549. Date of Electronic Publication: 2024 Jul 01.Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Genotype-Dependent Response to Desmopressin in Hemophilia A and Proposal of a Predictive Response Score.

• Authors : Guillet B; CRH, CRC-MHC (Centre de Référence de l'Hémophilie, Centre de Ressource et de Compétence des Maladies Hémorragiques Constitutionnelles), University Hospital, Rennes, France.; Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en santé, Environnement et Travail). UMR_S 1085, Rennes, France.

Subjects: Hemophilia A*/Hemophilia A*/Hemophilia A*/drug therapy ; Hemophilia A*/Hemophilia A*/Hemophilia A*/blood ; Hemophilia A*/Hemophilia A*/Hemophilia A*/genetics

• Source: Thrombosis and haemostasis [Thromb Haemost] 2024 Oct; Vol. 124 (10), pp. 922-936. Date of Electronic Publication: 2024 May 17.Publisher: Thieme Country of Publication: Germany NLM ID: 7608063 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2567-689X

Record details

Effects of long-term desmopressin treatment for nocturia in older people.

• Authors : Kurose H; Department of Urology, Chikugo City Hospital, Chikugo, Fukoka, Japan.; Department of Urology, Kurume University School of Medicine, Kurume, Fukoka, Japan.

Subjects: Nocturia*/Nocturia*/Nocturia*/drug therapy ; Nocturia*/Nocturia*/Nocturia*/etiology ; Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/Deamino Arginine Vasopressin*/administration & dosage

• Source: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2024 Oct; Vol. 31 (10), pp. 1114-1120. Date of Electronic Publication: 2024 Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Shilpa Medicare gains as its arm gets certificate of suitability from EDQM.

Subjects: PEPTIDES; DESMOPRESSIN

• Source: Ace Analyser: Company News. 10/4/2024, pN.PAG-N.PAG. 1p.

Record details